Index


Index


Page numbers followed by “f” indicate figures, “t” indicate tables, and “b” indicate boxes.


A


A delta fiber, 41-43


Abacavir, 371, 372b-374b

Abatacept, 338b-339b, 340

ABC assessment

in abdominal trauma, 1258

in chest trauma, 682, 1162

in esophageal trauma, 1218

in fracture, 1150, 1150b

in spinal cord injury, 969

in traumatic brain injury, 1025

in upper gastrointestinal bleeding, 1231b

ABCDE skin assessment, 459

Abciximab

for coronary artery disease, 839

for peripheral arterial disease, 790-791

for venous thromboembolism, 802

Abdomen, quadrants of, 1183f, 1183t

Abdominal aorta, 1466f

Abdominal aortic aneurysm, 792

Abdominal aortic aneurysm resection, 794-795, 794b

Abdominal assessment, 1183, 1183f, 1183t

in cirrhosis, 1297-1298, 1298f

in colorectal cancer, 1246-1247

in Crohn’s disease, 1281

in hematologic assessment, 863

in herniation, 1244

in kidney evaluation, 1475-1476

in spinal cord injury, 970

in urinary incontinence, 1500

Abdominal bruit, 1184

Abdominal distention

in diverticular disease, 1285

in enteral nutrition, 1346

in gastroenteritis, 1271b

in intestinal obstruction, 1255

in irritable bowel syndrome, 1241

in strangulated hernia, 1243

Abdominal fistula in chronic pancreatitis, 1328

Abdominal girth measurement, 1298, 1298f

Abdominal herniation, 1243-1245, 1243f

Abdominal mass, 1183b

in ovarian cancer, 1626

Abdominal myocutaneous flap, 1604t

Abdominal pain

in acute pancreatitis, 1322-1324

in appendicitis, 1267, 1267f

in black widow spider bite, 144

in botulism, 1290

bromocriptine-related, 1375

in cholecystitis, 1317

in chronic pancreatitis, 1326

in coral snake envenomation, 142

in Crohn’s disease, 1281

in diverticulitis, 1285

evaluation of, 1182

in gastric cancer, 1235

in hydronephrosis, hydroureter, and urethral stricture, 1522-1523

in intestinal obstruction, 1255

in irritable bowel syndrome, 1240-1241

in pancreatic cancer, 1330

in pelvic inflammatory disease, 1664

in peritonitis, 1269

in sickle cell disease, 872

in systemic lupus erythematosus, 345

Abdominal radiography

in acute kidney injury, 1543

in acute pancreatitis, 1324

in cirrhosis, 1299

in intestinal obstruction, 1256

in peritonitis, 1269

Abdominal surgery

delayed peristalsis after, 290

for peritonitis, 1269

skin preparation for, 255f

Abdominal thrust maneuver, 588f

Abdominal trauma, 1162, 1258-1260, 1258b

Abdominal ultrasonography

in diverticular disease, 1285

in pelvic inflammatory disease, 1664

in reproductive assessment, 1584

Abdominoperineal resection, 1248

Abducens nerve, 912t

Abduction, 1112f



AbioCor Implantable Replacement Heart, 754f

Ablative surgery

for bone cancer, 1136

for cervical cancer, 1625b

for dysfunctional uterine bleeding, 1613

for liver cancer, 1311

percutaneous alcohol septal ablation in, 768

percutaneous radiofrequency catheter ablation in, 728

for renal cell carcinoma, 1533

for thyroid cancer, 1405-1406

transurethral needle ablation in, 1635

Abnormal heart sounds, 700-701

ABO system, 899t

Abortive therapy in migraine, 929-930, 930t

Above-knee amputation, 1163f

Abrasion, corneal, 1057

Abscess

in amebiasis, 1288-1289

anorectal, 1287, 1287b

brain, 1036

hepatic, 1310

inadequate antimicrobial therapy and, 443-444

intra-abdominal, 1444

lung, 658

pancreatic, 1328-1329

peritonsillar, 644

prostatic, 1649

in pyelonephritis, 1523-1524

regional anesthesia-associated, 276

in ulcerative colitis and Crohn’s disease, 1273t

Absence seizure, 932

Absolute granulocyte count, 307

Absolute homelessness, 32

Absolute neutrophil count, 307

Absorbable sutures, 281

Absorption, 1178-1179

Absorption atelectasis, 564, 564b

Abstinence syndrome, 44-45

Acalculia, 1009

Acalculous cholecystitis, 1316

Acarbose, 1423b-1427b, 1429

ACC/AHA staging system, 745

Accelerated graft atherosclerosis, 315

Acceleration injury, 1021, 1022f, 1148

Acceleration-deceleration injury, 131-132

Accessory duct of Santorini, 1180f

Accessory muscles of respiration, 547

Accessory nerve, 912t

Accidental decannulation, 571, 571b, 575b

Accidental extubation, 675

Acclimatization, 151

Accolate, See Zafirlukast

Accommodation, 1043

Accutane, See Isotretinoin

AccuVein AV300 vein illumination device, 214, 214f


Acebutolol, 723b-726b

Acetaminophen, 51

for fever, 446

for lupus, 346

for migraine, 929-930

nephrotoxicity of, 1475

for osteoarthritis pain, 322

for sinusitis, 642

Acetazolamide, 152

Acetoacetic acid, 1420

Acetone, 1413, 1420

Acetylcholine, 941

Acetylcholine receptor antibodies, 992

Acetylcholinesterase, 944, 952

Acetylcysteine, 619

Achilles’ reflex, 917f

Achilles tendon rupture, 1172

Achlorhydria, 1234

Acid burn, 518

Acid deficit, 207, 207f

Acid suppression

in peptic ulcer disease, 1231-1232

in Zollinger-Ellison syndrome, 1234

Acid-base assessment, 199b, 204b

Acid-base balance, 196-201

acids and, 197, 197f

bases and, 197

bicarbonate ions and, 198, 198f

buffers and, 197-198, 197f-198f

carbon dioxide and hydrogen ions and, 198-199, 198f-199f

kidney role in regulation of, 1468

postoperative assessment of, 289

regulatory actions and mechanisms in, 199-201, 199b, 200t

chemical, 200

compensation process and, 201

kidney and, 201

respiratory, 200-201, 201f

sources of acids and bicarbonate, 199

Acid-base imbalance, 202-209

acidosis in, 202-204, 203t, 204b

combined metabolic and respiratory, 204

history in, 204

laboratory assessment in, 205-206, 205b, 206f

metabolic, 202-203

physical assessment in, 204-205, 204b

psychosocial assessment in, 205

respiratory, 203-204, 206-207

alkalosis in, 207-208, 207f, 207t, 208b

in chronic kidney disease, 1548

older adult and, 202b

Acidosis, 202-204, 203t, 204b

in abdominal trauma, 1259

in chronic glomerulonephritis, 1529

in chronic kidney disease, 1548

in chronic obstructive pulmonary disease, 613

combined metabolic and respiratory, 204

in diabetic ketoacidosis, 1456

history in, 204

in hypovolemic shock, 813

laboratory assessment in, 205-206, 205b, 206f

metabolic, 202-203, 203t

in chronic kidney disease, 1551

combined respiratory and, 197-198

in diabetes mellitus, 1413

in intestinal obstruction, 1254

laboratory assessment in, 205, 205b

in pulmonary embolism, 664

physical assessment in, 204-205, 204b

psychosocial assessment in, 205

respiratory, 203-204, 203t, 206-207

combined metabolic and, 197-198

laboratory assessment in, 205, 205b

in pulmonary embolism, 664

Acid(s), 197, 197f

kidney formation of, 201

sources of, 199

Acinus, 546, 547f

Aciphex, See Rabeprazole

Acitretin, 353


Acorn cardiac support device, 754

Acoustic neuroma, 1031, 1097

Acquired immunodeficiency syndrome, 358-380

antibody tests in, 368-369

classification of, 360, 360t

community-based care in, 378-380

complementary and alternative medicine for, 375

confusion in, 377-378

diarrhea in, 376-377

drug therapy for, 370-375, 371b-374b

endocrine complications in, 367, 368t

genetic considerations in, 360b

health care resources for, 380

history in, 365

HIV genotype test in, 369b

home care management in, 378-379, 379b

immune enhancement for, 375

incidence and prevalence of, 361, 361b, 361f

infection prevention in, 370-375, 370b-371b

infectious process in, 358-361, 358f-359f

key features of, 365b

lymphocyte counts in, 368

malignancies in, 367, 367f

nutrition and, 376

older adult and, 361b, 375b

opportunistic infections in, 365-367, 366f

oral disorders in, 1193

oral hairy leukoplakia in, 1195

oxygenation enhancement in, 375-376

pain management in, 376

parenteral transmission of, 362-363

perinatal transmission of, 363

postexposure prophylaxis to, 363b-364b

progression of, 361

psychosocial assessment in, 368

psychosocial preparation in, 379-380

self-esteem and, 378

sexual transmission of, 362, 362b

skin integrity and, 377

social contact and, 378

teaching for self-management in, 379, 379b

testing for, 363-364, 364b

transmission and health care workers, 363, 364b

viral load testing in, 369

women and, 361b

Acromegaly, 1374, 1375f, 1376b

Actemra, See Tocilizumab


Acticoat, 534b-535b

Actinic keratosis, 502, 502t

Actinic lentigo, 456f

Activated partial thromboplastin time

perioperative assessment of, 249b-250b

in pulmonary embolism, 665

before unfractionated heparin therapy, 800, 800b

Activated protein C, 824

Active euthanasia, 119

Active immunity, 312, 435

Active range of motion, 1111-1112

Activities of daily living

bone cancer and, 1136

dyspnea and, 551t

myasthenia gravis and, 994

peripherally inserted central catheter and, 217

pressure ulcer and, 482

rehabilitation and, 94

spinal cord injury and, 974

Activity

after hysterectomy, 1620

in asthma, 611

coronary artery disease and, 833

heart failure and, 756-757

leukemia and, 890, 890b

older adult and, 17-18, 18f

postoperative, 294

Activity therapist, 91

Activity tolerance

in chronic obstructive pulmonary disease, 621-622

in coronary artery disease, 840-841, 840b-841b

Activity-exercise pattern

in acid-base assessment, 204b

in cardiovascular assessment, 693b

in endocrine assessment, 1366b

in hematologic assessment, 861b

in musculoskeletal assessment, 1110b

in neurologic assessment, 914b

in respiratory assessment, 550b

Actonel, See Risedronate

Actoplus Met, 1423b-1427b

Actos, See Pioglitazone

Acular, See Ketorolac


Acupoints, 12-13

Acupressure, 12-13

for migraine, 931

Acupuncture, 12-13

for migraine, 931

for pain management, 61

Acupuncture and moxibustion, 1242

Acute abdomen series, 1185-1186

Acute adrenal insufficiency, 1381-1382

in Cushing’s disease, 1389

emergency care in, 1382b

Acute bacterial prostatitis, 1649

Acute care center in disaster, 159

Acute cholecystitis, 1316, 1316f

Acute compartment syndrome

in abdominal trauma, 1259

fracture and, 1145-1146, 1146b

monitoring for, 1156, 1157b

Acute coronary syndromes, 701, 829-831, 830f-831f

Acute gastritis, 1220-1221, 1222b

Acute gastroduodenal ulcer after burn injury, 517

Acute glaucoma, 1063

Acute glomerulonephritis, 1527, 1527t, 1528b

after streptococcal infection, 642, 643t

Acute gout, 349

Acute hematogenous osteomyelitis, 1131

Acute idiopathic polyneuritis, 987

Acute inflammatory bowel disorders, 1266-1272

appendicitis in, 1267-1268, 1267b, 1267f

gastroenteritis in, 1270-1272, 1270t, 1271b-1272b

peritonitis in, 1268-1270, 1268b-1269b

Acute inflammatory demyelinating polyneuropathy, 987

Acute ischemic stroke, 1014

Acute kidney injury, 1538-1541

abdominal aortic aneurysm resection-related, 794

after liver transplantation, 1312t

characteristics of, 1538t

classification of risk for, 1538-1539, 1539t

continuous renal replacement therapy for, 1546

dialysis therapies for, 1545-1546, 1545f

drug therapy for, 1543, 1544b

etiology of, 1540

health promotion and maintenance in, 1540-1541

history in, 1541

imaging assessment in, 1543

incidence and prevalence of, 1540

kidney biopsy in, 1543

laboratory assessment in, 1542-1543, 1542b

nutrition therapy for, 1543-1545

pathophysiology of, 1538-1540

phases of, 1540t

physical assessment in, 1541-1542, 1541b

posthospital care in, 1546

potentially nephrotoxic substances and, 1540t

in tumor lysis syndrome, 432-433

types of, 1539-1540, 1539t

volume depletion in, 1541b

Acute leukemia, 882b, 883-884

Acute low back pain, 962

Acute lung injury, 671, 672t

Acute lymphocytic leukemia, 881

Acute mountain sickness, 151

Acute myelogenous leukemia, 881

Acute myocardial infarction, 829-831

cardiac rehabilitation after, 851, 851b

chest pain in, 696t

COX-2 inhibiting drugs and, 322b

electrocardiographic changes and patterns in, 831f

fibrinolytic drugs for, 862

heart failure after, 842, 842t

home care management after, 850b

key features of, 835b

older adult and, 835b

reperfusion therapy for, 839-840

risk in diabetes mellitus, 1413

during surgery, 243-244

twelve-lead electrocardiogram in, 835

Acute nephritic syndrome, 1527

Acute normovolemic hemodilution, 901

Acute osteomyelitis, 1132, 1132b

Acute otitis media, 1092

Acute pain, 41

characteristics of, 40t

fentanyl for, 52

in peptic ulcer disease, 1229-1230

physical assessment in, 46

psychosocial assessment in, 40

Acute pancreatitis, 1321-1322

community-based care in, 1325-1326

complications of, 1322, 1322t, 1324b

etiology and genetic risk in, 1322

history in, 1322-1323

imaging assessment in, 1324

incidence and prevalence of, 1322

laboratory assessment in, 1323-1324, 1323t

nutrition in, 1325

pain management in, 1324-1325

pathophysiology of, 1321-1322, 1321f

physical assessment in, 1323, 1323b

psychosocial assessment in, 1323

respiratory status in, 1325b

Acute paronychia, 465

Acute pericarditis, 765

Acute peripheral arterial occlusion, 791-792, 792b

Acute pharyngitis, 642

Acute phase of burn, 530

burn wound infection and, 533-536, 534b-535b

cardiopulmonary assessment in, 530

immune assessment in, 530, 530t-531t

maintenance of mobility in, 536-538, 537f

musculoskeletal assessment in, 530

neuroendocrine assessment in, 530

positioning to prevent contractures in, 537b

supporting self-image in, 538

weight loss control in, 536

wound care in, 531-533, 532t, 533f

Acute protein-energy malnutrition, 1340

Acute pyelonephritis, 1523, 1524b

Acute radiation cystitis, 1640

Acute rehabilitation, 90

Acute rejection, 315

of kidney transplant, 1570, 1570t

of liver transplant, 1312t

Acute renal failure, See Acute kidney injury

Acute respiratory distress syndrome, 671-672, 672b, 672t

burn-related, 529-530

in septic shock, 823

Acute respiratory failure, 669-671, 670t, 671f

Acute sialadenitis, 1200-1201

Acute thyroiditis, 1404

Acute transfusion reactions, 900-901

Acute tubular necrosis, 1539, 1570

Acute viral rhinitis, 641

Acyclovir

for Bell’s palsy, 1001

for genital herpes, 1657

for herpes simplex stomatitis, 1195

for viral encephalitis, 941

for viral skin infection, 494

Adalat PA, See Nifedipine

Adalimumab

for Crohn’s disease, 1282

for psoriasis, 500, 501b

for rheumatoid arthritis, 338b-339b, 340

for ulcerative colitis, 1275

Adam’s apple, 545f

Adaptive devices for functional mobility, 99, 100t

Adaptive immunity, 312

Addiction, 44-45

Addisonian crisis, 1381-1382

Addison’s disease, 1382, 1382b

Add-on device in infusion therapy, 221

Adduction, 1112f

Adenine, 67, 67f

Adenocarcinoma

colorectal, 1245

esophageal, 1211-1212

gastric, 1234

prostate, 1637

renal, 1532

Adenocard, See Adenosine

Adenohypophysis, 1361, 1372

Adenoidectomy, 644

Adenoids, 544f, 545

Adenoma

pituitary, 1374

testicular, 1643

Adenosine, 723b-726b, 733

Adenosine triphosphate, 862


Adhesive transparent film dressing, 486t

Adiponectin, 1349

Adipose tissue, 247, 452

Adjustable gastric band, 1353, 1354f

Adjuvant analgesics, 50t, 58-59

Adjuvant therapy

for breast cancer, 1604-1607

for cancer, 414

Administration set, 220-222, 222f, 225

Administrative review after critical event, 163

Adrenal cortex, 1362, 1362f

hormones secreted by, 1359t, 1362t

interaction with hypothalamus and anterior pituitary, 1360-1361, 1360f

Adrenal crisis, 1381

Adrenal Cushing’s disease, 1385

Adrenal gland, 1362-1363, 1362f, 1362t-1363t, 1466f

hyperfunction of, 1384-1385

Cushing’s disease in, 1384-1385, 1384f, 1385b, 1385t

hyperaldosteronism in, 1390

pheochromocytoma in, 1390-1391

hypofunction of, 1381-1382

drug therapy for, 1383, 1384b

emergency care in, 1382b

history in, 1382

imaging assessment in, 1383

laboratory assessment in, 1383, 1383b

pathophysiology of, 1381-1382, 1382t

physical assessment in, 1382, 1382b, 1383f

psychosocial assessment in, 1383

Adrenal glucocorticoids

for rheumatoid arthritis, 340

role in bone growth and metabolism, 1108

Adrenal insufficiency

in acquired immunodeficiency syndrome, 367

after nephrectomy, 1533

Adrenal medulla, 1362-1363, 1362f

Adrenal steroids, 1362

Adrenalectomy, 1387

Adrenalin, See Epinephrine

Adrenal-mediated hypertension, 777

Adrenergic agonists for glaucoma, 1066b-1067b

Adrenocorticotropic hormone, 1361t, 1362

corticotropin-releasing hormone stimulation of, 1360-1361, 1360f

deficiency of, 1372, 1373b

overproduction of, 1374, 1376b

paraneoplastic syndromes associated with lung cancer and, 631t

Adrenocorticotropic hormone stimulation test, 1383

Adriamycin, See Doxorubicin

Adrucil, See 5-Fluouracil

Adsorbocarpine, See Pilocarpine

Adult health nursing, 1

Adult respiratory distress syndrome, 671

Advance directives, 107-108, 278, 757

Advanced Cardiac Life Support, 127, 127t, 729, 736-737

Advanced cirrhosis, 1296

Advanced Disaster Life Support, 158

Advanced older adult population, 16

Advancing Research and Clinical Practice through Close Collaboration model of evidence-based practice, 83-84

Adventitious breath sounds, 554, 555t

Adverse drug effects, 20, 21t

Adverse event during emergency care, 125

Advicor, 775

Aerophagia, 1211

Aerosol inhaler, 609, 609b, 609f-610f

Aerosol mask, 567-568, 568t

Aerosolization of Mycobacterium tuberculosis, 653, 654f

Aesthetic plastic surgery, 505

Afferent arteriole, 1467, 1467f-1468f, 1469t, 1470f

Afferent loop syndrome, 1237

Afferent neuron, 906

Afferent pathway, 910

Afinitor, See Everolimus

Africanized bees, 145

After-drop in hypothermia, 149

Afterload, 690, 747, 751

Age

bone healing and, 1145b

cancer development and, 404-405, 405b

coronary artery disease and, 831b

increased surgical risk with, 244t

potassium loss and, 184

urinary tract infection and, 1490t

Age-related macular degeneration, 1068

Agglutination, 311, 311f

Aggrastat, See Tirofiban

Aging

cardiovascular changes with, 692, 692b

endocrine changes with, 1365, 1365b

eye changes with, 1043-1044, 1043b, 1044f

fluid balance changes with, 170b

gastrointestinal changes with, 1180-1181, 1181b

hearing changes with, 1079, 1080b

hematologic changes with, 860

immune function changes with, 304b

increasing complications in burn and, 521b

musculoskeletal changes with, 1109, 1109b

neurologic changes with, 911-913, 912b

renal changes with, 1472, 1473b

reproductive system changes in, 1578, 1579b

respiratory changes with, 548, 549b

with spinal cord injury, 975b

Agitation

in Alzheimer’s disease, 953

management in end-of-life care, 115, 115b

Agnosia

in Alzheimer’s disease, 948

in stroke, 1009-1011

Agraphia, 1009


AIDS dementia complex, 368

AIDS wasting syndrome, 368

Air embolism

central venous catheter-related, 231t

changing administration set and, 225

Air warming and humidification in tracheostomy, 574, 574b

Airborne precautions, 440, 442t

in severe acute respiratory syndrome, 653

in tuberculosis, 657, 657f

Airborne transmission, 436

Air-fluidized therapy, 101

Airway, 546, 546f-547f

direct injury in burn, 521

primary survey and, 132-134, 132b, 132f, 134t

Airway assessment

after discharge from PACU, 288b

in burn injury, 521-522, 521t

in facial trauma, 583

in laryngeal trauma, 586, 586b

Airway management

in burn injury, 525-526

in chronic obstructive pulmonary disease, 618-621, 619b

in Guillain-Barr[ac]e syndrome, 989, 989b

in laryngeal trauma, 586, 586b

in lung cancer, 637-638

in oral cancer, 1197, 1199b

postoperative, 293-294

in bariatric surgery, 1354

in head and neck surgery, 592

in spinal cord injury, 971, 971b

in traumatic brain injury, 1025, 1025b

Airway obstruction, 586-588, 588f

burn-related, 521t

in facial trauma, 583

in head and neck cancer, 590-594

in pharyngitis, 643b

in pneumonia, 651

respiratory acidosis and, 203

in status asthmaticus, 611

in tonsillitis, 644

in vocal cord paralysis, 585

Airway pressure-release ventilation, 672-673, 678

Akarpine, See Pilocarpine


Akinesia, 941

Akinetic seizure, 932

Alanine aminotransferase

in acute pancreatitis, 1323-1324

in cirrhosis, 1298, 1299t

in gastrointestinal assessment, 1185

in hepatitis, 1308

normal adult range for, 1186b

Alarm system of ventilator, 679-680, 680t

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Nov 2, 2016 | Posted by in NURSING | Comments Off on Index

Full access? Get Clinical Tree

Get Clinical Tree app for offline access